Skip to content
Clinical Trials – home

Gornoslaskie Centrum Mwdyczne

Verifiedinfo

Poland Ul. Ziolowa 45/47, 40-635 Katowice, Poland

  • 20 trials recruiting
  • Atrial fibrillation · Ischaemic stroke · Acute coronary syndrome
  • Adults and children

About Specializations

Gornoslaskie Centrum Mwdyczne in Katowice, Poland specialises in clinical trials of conditions such as Atrial fibrillation, Ischaemic stroke, Acute coronary syndrome, Pulmonary arterial hypertension, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiology and Antithrombotic Therapy

The medical center is at the forefront of cardiology research, particularly in the development of innovative antithrombotic therapies for patients with atrial fibrillation (AF) who have undergone percutaneous coronary intervention (PCI). The center's research focuses on optimizing treatment regimens to enhance patient outcomes and minimize risks.

  • Innovative P2Y12 Inhibitor Monotherapy
  • Direct Oral Anticoagulant (DOAC) Strategies
  • Management of Bleeding Risks

Through its pioneering studies, the center is contributing significantly to the understanding of how to balance efficacy and safety in antithrombotic therapy, potentially reshaping standard care practices for AF patients post-PCI.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Ziolowa 45/4740-635 KatowicePoland
Recruiting now
20 trials
Conditions studied
33
Partner status
Verified

More sites in KatowicePoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

45 clinical trials

Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Diamedica Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:65+ years
  • Substances:Sodium Chloride
  • Sponsor:Wroclaw Medical University
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:HUMAN IGG4 KAPPA MONOCLONAL ANTIBODY AGAINST PLATELET-DERIVED GROWTH FACTOR SUBUNIT B
  • Sponsor:Regeneron Pharmaceuticals Inc.

Dyslipidaemia+1

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride Solution 0.9%
  • Sponsor:TargED Biopharmaceuticals B.V.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Medical University Of Lodz
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Agencja Badań Medycznych
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.